{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:26:06Z","timestamp":1773923166194,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T00:00:00Z","timestamp":1534809600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007446","name":"King Khalid University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Journal of Biological Sciences"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.sjbs.2018.08.019","type":"journal-article","created":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T16:16:16Z","timestamp":1534954576000},"page":"1676-1681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Development of Rift Valley fever (RVF) vaccine by genetic joining of the RVF-glycoprotein Gn with the strong adjuvant subunit B of cholera toxin (CTB) and expression in bacterial system"],"prefix":"10.1016","volume":"26","author":[{"given":"Essam H.","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramadan","family":"Taha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamed A.","family":"Ghramh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Kilany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sjbs.2018.08.019_b0005","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0264-410X(02)00702-8","article-title":"Vaccinology: past achievements, present roadblocks and future promises","volume":"21","author":"Andre","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.sjbs.2018.08.019_b0010","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/vbz.2012.1160","article-title":"Vertical transmission of Rift Valley fever virus without detectable maternal viremia","volume":"13","author":"Antonis","year":"2013","journal-title":"Vector-Borne Zoonotic Dis."},{"key":"10.1016\/j.sjbs.2018.08.019_b0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4269\/ajtmh.2010.09-0293","article-title":"Risk Factors for Severe Rift Valley Fever Infection in Kenya, 2007","volume":"83","author":"Anyangu","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.sjbs.2018.08.019_b0020","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1046-5928(02)00026-8","article-title":"Synthesis of cholera toxin B subunit gene: cloning and expression of a functional 6XHis-tagged protein in Escherichia coli","volume":"25","author":"Areas","year":"2002","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.sjbs.2018.08.019_b0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4103\/0255-0857.108705","article-title":"Comparison of two recombinant systems for expression of cholera toxin B subunit from Vibrio cholerae","volume":"31","author":"Bakhshi","year":"2013","journal-title":"Indian J. Med. Microbiol."},{"key":"10.1016\/j.sjbs.2018.08.019_b0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0923-2516(07)80002-1","article-title":"The effect of neutralizing monoclonal antibodies on early events in Rift Valley fever virus infectivity","volume":"145","author":"Besselaar","year":"1994","journal-title":"Res. Virol."},{"key":"10.1016\/j.sjbs.2018.08.019_b0035","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.sjbs.2018.08.019_b0040","first-page":"157","article-title":"Antibody response in cattle to oil emulsion rabies and ephemeral fever vaccines","volume":"54","author":"Cameron","year":"1987","journal-title":"Onderstepoort. J. Vet. Res."},{"key":"10.1016\/j.sjbs.2018.08.019_b0045","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1073\/pnas.86.7.2172","article-title":"One-step preparation of competent Escherichia coli: transformation and storage of bacterial cells in the same solution","volume":"86","author":"Chung","year":"1989","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.sjbs.2018.08.019_b0050","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/path.1700340418","article-title":"Enzootic hepatitis or Rift Valley fever. An undescribed virus disease of sheep, cattle and man from East Africa","volume":"34","author":"Daubney","year":"1931","journal-title":"J. Pathol. Bacteriol."},{"key":"10.1016\/j.sjbs.2018.08.019_b0055","doi-asserted-by":"crossref","DOI":"10.1186\/s12934-015-0393-3","article-title":"Exacerbation of substrate toxicity by IPTG in Escherichia coli BL21(DE3) carrying a synthetic metabolic pathway","volume":"14","author":"Dvorak","year":"2015","journal-title":"Microb. Cell Fact."},{"key":"10.1016\/j.sjbs.2018.08.019_b0060","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1089\/vbz.2014.1650","article-title":"A glycoprotein subunit vaccine elicits a strong Rift Valley fever virus neutralizing antibody response in sheep","volume":"14","author":"Faburay","year":"2014","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.sjbs.2018.08.019_b0065","doi-asserted-by":"crossref","first-page":"27719","DOI":"10.1038\/srep27719","article-title":"A recombinant Rift Valley fever virus glycoprotein subunit vaccine confers full protection against Rift Valley fever challenge in sheep","volume":"6","author":"Faburay","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.sjbs.2018.08.019_b0070","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.virol.2011.08.025","article-title":"Effects of glycosylation on antigenicity and immunogenicity of classical swine fever virus envelope proteins","volume":"420","author":"Gavrilov","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.sjbs.2018.08.019_b0075","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.virol.2006.09.035","article-title":"The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection","volume":"359","author":"Gerrard","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.sjbs.2018.08.019_b0080","doi-asserted-by":"crossref","first-page":"12200","DOI":"10.1128\/JVI.76.23.12200-12210.2002","article-title":"Characterization of the Golgi Retention Motif of Rift Valley Fever Virus GN Glycoprotein","volume":"76","author":"Gerrard","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.sjbs.2018.08.019_b0085","series-title":"Molecular Cloning: A Laboratory Manual","author":"Green","year":"2012"},{"key":"10.1016\/j.sjbs.2018.08.019_b0090","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1128\/JVI.02148-08","article-title":"NSs Protein of Rift Valley Fever Virus Induces the Specific Degradation of the Double-Stranded RNA-Dependent Protein Kinase","volume":"83","author":"Habjan","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.sjbs.2018.08.019_b0095","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.genrep.2017.11.008","article-title":"Genetic fusion of tetanus toxin fragment C (Hc) gene to cholera toxin subunit B (CTB) gene as a preparatory step for double vaccine production","volume":"10","author":"Ibrahim","year":"2018","journal-title":"Gene Reports"},{"key":"10.1016\/j.sjbs.2018.08.019_b0100","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3390\/v3050493","article-title":"The pathogenesis of Rift Valley fever","volume":"3","author":"Ikegami","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.sjbs.2018.08.019_b0105","doi-asserted-by":"crossref","first-page":"8421","DOI":"10.1128\/JVI.02641-06","article-title":"Characterization of Rift Valley fever virus transcriptional terminations","volume":"81","author":"Ikegami","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.sjbs.2018.08.019_b0110","doi-asserted-by":"crossref","first-page":"e25027","DOI":"10.1371\/journal.pone.0025027","article-title":"Anti-nucleocapsid protein immune responses counteract pathogenic effects of rift valley fever virus infection in mice","volume":"6","author":"Jansen van Vuren","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.sjbs.2018.08.019_b0115","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1016\/j.vaccine.2012.03.027","article-title":"Efficacy of three candidate Rift Valley fever vaccines in sheep","volume":"30","author":"Kortekaas","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.sjbs.2018.08.019_b0120","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.sjbs.2018.08.019_b0125","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0065-3519(99)80043-3","article-title":"Vaccination of wildlife against rabies: successful use of a vectored vaccine obtained by recombinant technology","volume":"41","author":"Mackowiak","year":"1999","journal-title":"Adv. Vet. Med."},{"key":"10.1016\/j.sjbs.2018.08.019_b0130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1051\/vetres\/2010033","article-title":"Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention","volume":"41","author":"Pepin","year":"2010","journal-title":"Vet. Res."},{"key":"10.1016\/j.sjbs.2018.08.019_b0135","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.vaccine.2015.12.030","article-title":"Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans","volume":"34","author":"Pittman","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.sjbs.2018.08.019_b0140","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1016\/j.vaccine.2011.02.037","article-title":"Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study","volume":"29","author":"Rusnak","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.sjbs.2018.08.019_b0145","doi-asserted-by":"crossref","DOI":"10.1002\/0471140864.ps0521s52","article-title":"Recombinant protein complex expression in E. Coli","author":"Selleck","year":"2008","journal-title":"Curr. Protoc. Protein Sci."},{"key":"10.1016\/j.sjbs.2018.08.019_b0150","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ymeth.2005.09.013","article-title":"Mucosal immunization using recombinant plant-based oral vaccines","volume":"38","author":"Streatfield","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.sjbs.2018.08.019_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-3083.2009.02321.x","article-title":"Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit","volume":"71","author":"Sun","year":"2010","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.sjbs.2018.08.019_b0160","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1016\/j.vaccine.2006.06.041","article-title":"Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever","volume":"24","author":"Wallace","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.sjbs.2018.08.019_b0165","unstructured":"WHO, 2017. Rift Valley fever, Fact sheet. http:\/\/www.who.int\/mediacentre\/factsheets\/fs207\/en\/."},{"key":"10.1016\/j.sjbs.2018.08.019_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-387040-7.00021-4","article-title":"Rabies research in resource\u2014poor countries","author":"Wilde","year":"2011","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.sjbs.2018.08.019_b0175","doi-asserted-by":"crossref","first-page":"13335","DOI":"10.1128\/JVI.01238-07","article-title":"NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis","volume":"81","author":"Won","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.sjbs.2018.08.019_b0180","doi-asserted-by":"crossref","first-page":"e59210","DOI":"10.1371\/journal.pone.0059210","article-title":"The nucleocapsid protein of Rift Valley fever virus is a potent human CD8(+) T cell antigen and elicits memory responses","volume":"8","author":"Xu","year":"2013","journal-title":"PLoS One"}],"container-title":["Saudi Journal of Biological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319562X18301943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319562X18301943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T16:59:07Z","timestamp":1761152347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319562X18301943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1319562X18301943"],"URL":"https:\/\/doi.org\/10.1016\/j.sjbs.2018.08.019","relation":{},"ISSN":["1319-562X"],"issn-type":[{"value":"1319-562X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of Rift Valley fever (RVF) vaccine by genetic joining of the RVF-glycoprotein Gn with the strong adjuvant subunit B of cholera toxin (CTB) and expression in bacterial system","name":"articletitle","label":"Article Title"},{"value":"Saudi Journal of Biological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sjbs.2018.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Production and hosting by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}